• FDA AdCom roster shrinks as two quit over Aduhelm approval firstwordpharma
    June 10, 2021
    Mayo Clinic neurologist David Knopman on Wednesday became the second member of the FDA's Peripheral and Central Nervous System Drugs Advisory Committee (AdCom) to resign in protest at the agency's decision earlier this week to approve Biogen
PharmaSources Customer Service